Whose side are you on?

J Taieb¹

Affiliations

Free article

Editorial

J Taieb. Ann Oncol. 2017.

Free article

. 2017 Aug 1;28(8):1685-1686.

doi: 10.1093/annonc/mdx270.

J Taieb¹

¹ Department of Hepatogastroenterology and GI Oncology, Georges Pompidou European Hospital, Sorbonne Paris Cité/Paris Descartes University, Paris, France.

No abstract available

Comment on

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
Arnold D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, Heinemann V, Van Cutsem E, Pignon JP, Tabernero J, Cervantes A, Ciardiello F. Arnold D, et al. Ann Oncol. 2017 Aug 1;28(8):1713-1729. doi: 10.1093/annonc/mdx175. Ann Oncol. 2017. PMID: 28407110 Free PMC article.
Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies.
Boeckx N, Koukakis R, Op de Beeck K, Rolfo C, Van Camp G, Siena S, Tabernero J, Douillard JY, André T, Peeters M. Boeckx N, et al. Ann Oncol. 2017 Aug 1;28(8):1862-1868. doi: 10.1093/annonc/mdx119. Ann Oncol. 2017. PMID: 28449055 Free PMC article.